chicken: novel target organs for progesterone and estrogen action. Mol. Cell. Endocrinol. 135, 79–91 7 Straub, S.G. et al. (2001) Progesterone inhibits insulin secretion by a membrane delimited, non-genomic action. Biosci. Rep. 21, 653–666 8 Magnaterra, R. et al. (1997) The effects of pregnancy steroids on adaptation of b cells to pregnancy involve the pancreatic glucose sensor glucokinase. J. Endocrinol. 155, 247–253 9 Nieuwenhuizen, A.G. et al. (1999) Progesterone stimulates pancreatic cell proliferation in vivo. Eur. J. Endocrinol. 140, 256–263 10 Kawai, M. and Kishi, K. (1999) Adaptation of pancreatic islet b-cells during the last third of pregnancy: regulation of b-cell function and proliferation by lactogenic hormones in rats. Eur. J. Endocrinol. 141, 419–425 11 Hamann, A. and Matthaei, S. (1996) Regulation of energy balance by leptin. Exp Clin. Endocrinol. Diabetes 104, 293–300 12 Chu, J.W. et al. (2001) Successful long-term treatment of refractory Cushing’s disease with high-dose mifepristone (RU 486). J. Clin. Endocrinol. Metab. 86, 3568–3573 13 Medina, D. et al. (2001) Mechanisms of hormonal prevention of breast cancer. Ann. New York Acad. Sci. 952, 23–35 1043-2760/03/$ - see front matter q 2003 Elsevier Science Ltd. All rights reserved. doi:10.1016/S1043-2760(03)00003-1 | Letter The role of chromogranin A and the control of secretory granule genesis and maturation Taeyoon Kim 1 , Jung-Hwa Tao-Cheng 2 , Lee E. Eiden 3 and Y. Peng Loh 1 1 Laboratory of Developmental Neurobiology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA 2 EM facility, National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, MD 20892, USA 3 Laboratory of Cellular and Molecular Regulation, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA In a recent Opinion article in Trends in Endocrinology and Metabolism [1], Day and Gorr review recent work in the chromogranin field, including our own work on chromo- granin A (CgA) and our proposal that CgA is an ‘on/off’ switch, acting at a post-transcriptional level, for the bio- genesis of neuroendocrine large dense-core secretory granules [2]. They raise the question of whether CgA plays a role as a universal master gene, ‘on/off’ switch, or assembly factor in the control of dense-core secretory granule biogenesis in endocrine and neuroendocrine cells. They argue that CgA is unlikely to act as such a switch only at the transcriptional level. We agree: our data show that suppression of CgA synthesis in PC12 cells causes an abolition of large dense-core secretory granule proteins, but not the mRNAs that encode them, clearly pointing to a post-transcriptional component of the action of CgA in granule biogenesis. Day and Gorr also point out that secretory granules exist in cells that do not synthesize CgA. These exceptions are particularly interesting. As pointed out by us previously [2], mast cells use a non- protein substance, heparin, to enable mast cell granule formation, and lactotrophs contain prolactin rather than CgA in their secretory granule. Our definition of an ‘on/off ’ switch for granulogenesis is a factor that regulates and is required for initiation of granule formation at the level of the trans-Golgi network (TGN). According to this defi- nition, molecules other than CgA, such as heparin [3], could function as ‘on/off’ switches for granule biogenesis, depending on cell type. Based on the fact that most endo- crine and neuroendocrine cells [4–6], as well as some exocrine cells [7], synthesize CgA, and our data implicat- ing CgA in large dense-core granule biogenesis in PC12 and 6T3 cells [2], CgA is likely to be the most widely used granulogenic factor in neuroendocrine cells. What of experiments in which overexpression of CgA does not reconstitute large dense-core secretory granule formation [8], or in which the spontaneous loss of regu- lated secretion in a PC12 variant cell cannot be rescued by exogenous CgA expression [9]? Tellingly, forced expression of CgA completely reconstitutes granule formation and function in PC12 cells in which endogenous CgA sup- pression first leads to loss of granulogenesis and regu- lated secretion [2], and forced expression of CgA in non-neuroendocrine cells likewise results in the formation of significant numbers of CgA containing large dense-core granule-like vesicles, albeit less abundant than the granule complement of normal endocrine cells [2]. Thus, in a cell with all other components predisposing to granulogenesis (PC12 cells), CgA is the post-translational ‘switch’ that turns it on, whilst in nonendocrine cells (e.g. fibroblasts), CgA might well act only as an assembly factor, because structures or organelles formed in the CgA-expressing fibroblasts (CV-1 cells) are most likely not bona fide secretory granules, in the sense that they contain pro- hormones and have prohormone processing capability, and so on. PC12 variant cells that have also permanently lost neurosecretion competence [9–12] cannot be expected to recover simply by overexpressing CgA [9], unless it can induce the expression of all the necessary genes, thus acting as a ‘master’ gene. However, CgA has never been proposed as such a gene. By contrast, PC12 and 6T3 cells have not permanently lost their synthesis of regulated secretory pathway proteins upon downregulation of CgA synthesis and thus exhibit reversible competence for neurosecretion upon restoration of CgA synthesis. Thus, our data from PC12 and 6T3 cells support the hypothesis that CgA not only acts as an assembly factor, but also controls large dense-core granule biogenesis through regulating the stability and hence availability of proteins required for functional secretory granule formation. This Corresponding author: Y. Peng Loh (ypl@codon.nih.gov). Update TRENDS in Endocrinology and Metabolism Vol.14 No.2 March 2003 56 http://tem.trends.com